Skip to main content
Top
Published in: Trials 1/2022

Open Access 01-12-2022 | Systemic Sclerosis | Research

Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial

Authors: Linda Kwakkenbos, Marie-Eve Carrier, Joep Welling, Brooke Levis, Alexander W. Levis, Maureen Sauve, Kimberly A. Turner, Lydia Tao, Kylene Aguila, Andrea Carboni-Jiménez, Mara Cañedo-Ayala, Sami Harb, Cornelia van den Ende, Marie Hudson, Ward van Breda, Christelle Nguyen, Isabelle Boutron, François Rannou, Brett D. Thombs, Luc Mouthon, on behalf of the SPIN Investigators

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Background

Systemic sclerosis (scleroderma; SSc) is a rare autoimmune connective tissue disease. Functional impairment of hands is common. The Scleroderma Patient-centered Intervention Network (SPIN)-HAND trial compared effects of offering access to an online self-guided hand exercise program to usual care on hand function (primary) and functional health outcomes (secondary) in people with SSc with at least mild hand function limitations.

Methods

The pragmatic, two-arm, parallel-group cohort multiple randomized controlled trial was embedded in the SPIN Cohort. Cohort participants with Cochin Hand Function Scale (CHFS) scores ≥ 3 and who indicated interest in using the SPIN-HAND Program were randomized (3:2 ratio) to an offer of program access or to usual care (targeted N = 586). The SPIN-HAND program consists of 4 modules that address (1) thumb flexibility and strength; (2) finger bending; (3) finger extension; and (4) wrist flexibility and strength. The primary outcome analysis compared CHFS scores 3 months post-randomization between participants offered versus not offered the program. Secondary outcomes were CHFS scores 6 months post-randomization and functional health outcomes (Patient-Reported Outcomes Measurement Information System profile version 2.0 domain scores) 3 and 6 months post-randomization.

Results

In total, 466 participants were randomized to intervention offer (N = 280) or usual care (N = 186). Of 280 participants offered the intervention, 170 (61%) consented to access the program. Of these, 117 (69%) viewed at least one hand exercise instruction video and 77 (45%) logged into the program website at least 3 times. In intent-to-treat analyses, CHFS scores were 1.2 points lower (95% CI − 2.8 to 0.3) for intervention compared to usual care 3 months post-randomization and 0.1 points lower (95% CI − 1.8 to 1.6 points) 6 months post-randomization. There were no statistically significant differences in other outcomes.

Conclusion

The offer to use the SPIN-HAND Program did not improve hand function. Low offer uptake, program access, and minimal usage among those who accessed the program limited our ability to determine if using the program would improve function. To improve engagement, the program could be tested in a group format or as a resource to support care provided by a physical or occupational therapist.

Trial registration

NCT03419208. Registered on February 1, 2018.
Appendix
Available only for authorised users
Literature
1.
go back to reference Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1:15002.CrossRef Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1:15002.CrossRef
2.
go back to reference Wigley FM, Hummers LK, et al. Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, et al., editors. Rheumatology. Philadelphia: Mosby; 2003. p. 1463–80. Wigley FM, Hummers LK, et al. Clinical features of systemic sclerosis. In: Hochberg MC, Silman AJ, Smolen JS, et al., editors. Rheumatology. Philadelphia: Mosby; 2003. p. 1463–80.
3.
go back to reference Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-Guern V, Cabane J, et al. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-item Short Form Health Survey. Arthritis Rheum. 2007;57:94–102.CrossRef Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-Guern V, Cabane J, et al. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-item Short Form Health Survey. Arthritis Rheum. 2007;57:94–102.CrossRef
4.
go back to reference Kallen MA, Mayes MD, Kriseman YL, de Achaval SB, Cox VL, Suarez-Almazor ME. The Symptom Burden Index: development and initial findings from use with patients with systemic sclerosis. J Rheumatol. 2010;37:1692.CrossRef Kallen MA, Mayes MD, Kriseman YL, de Achaval SB, Cox VL, Suarez-Almazor ME. The Symptom Burden Index: development and initial findings from use with patients with systemic sclerosis. J Rheumatol. 2010;37:1692.CrossRef
5.
go back to reference Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian national survey. Rheumatology. 2011;50:762–7.CrossRef Bassel M, Hudson M, Taillefer SS, Schieir O, Baron M, Thombs BD. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian national survey. Rheumatology. 2011;50:762–7.CrossRef
6.
go back to reference Poole JL. Musculoskeletal rehabilitation in the person with scleroderma. Curr Opin Rheumatol. 2010;22:205–12.CrossRef Poole JL. Musculoskeletal rehabilitation in the person with scleroderma. Curr Opin Rheumatol. 2010;22:205–12.CrossRef
7.
go back to reference Sandler RD, Matucci-Cerinic M, Hughes M. Musculoskeletal hand involvement in systemic sclerosis. Semin Arthritis Rheum. 2020;50:329–34.CrossRef Sandler RD, Matucci-Cerinic M, Hughes M. Musculoskeletal hand involvement in systemic sclerosis. Semin Arthritis Rheum. 2020;50:329–34.CrossRef
8.
go back to reference Sandqvist G, Eklund M, Akesson A, Nordenskiöld U. Daily activities and hand function in women with scleroderma. Scand J Rheumatol. 2004;33:102–7.CrossRef Sandqvist G, Eklund M, Akesson A, Nordenskiöld U. Daily activities and hand function in women with scleroderma. Scand J Rheumatol. 2004;33:102–7.CrossRef
9.
go back to reference Landim SF, Bertolo MB, Marcatto de Abreu MF, Del Rio AP, Mazon CC, Marques-Neto JF, et al. The evaluation of a home-based program for hands in patients with systemic sclerosis. J Hand Ther. 2019;32:313–21.CrossRef Landim SF, Bertolo MB, Marcatto de Abreu MF, Del Rio AP, Mazon CC, Marques-Neto JF, et al. The evaluation of a home-based program for hands in patients with systemic sclerosis. J Hand Ther. 2019;32:313–21.CrossRef
10.
go back to reference Poole JL, MacIntyre NJ, de Boer HN. Evidence-based management of hand and mouth disability in a woman living with diffuse systemic sclerosis (scleroderma). Physiother Can. 2013;65:317–20.CrossRef Poole JL, MacIntyre NJ, de Boer HN. Evidence-based management of hand and mouth disability in a woman living with diffuse systemic sclerosis (scleroderma). Physiother Can. 2013;65:317–20.CrossRef
11.
go back to reference Filippetti M, Cazzoletti L, Zamboni F, Ferrari P, Caimmi C, Smania N, et al. Effect of a tailored home-based exercise program in patients with systemic sclerosis: a randomized controlled trial. Scandin J Med Sci Sports. 2020;30:1675–84.CrossRef Filippetti M, Cazzoletti L, Zamboni F, Ferrari P, Caimmi C, Smania N, et al. Effect of a tailored home-based exercise program in patients with systemic sclerosis: a randomized controlled trial. Scandin J Med Sci Sports. 2020;30:1675–84.CrossRef
12.
go back to reference Yuen HK, Weng Y, Bandyopadhyay D, Reed SG, Leite RS, Silver RM. Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis. Clin Exp Rheumatol. 2011;29(suppl 65):26–32. Yuen HK, Weng Y, Bandyopadhyay D, Reed SG, Leite RS, Silver RM. Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis. Clin Exp Rheumatol. 2011;29(suppl 65):26–32.
13.
go back to reference Bongi SM, Del Rosso A, Galluccio F, Sigismondi F, Miniati I, Conforti ML, et al. Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis. Clin Rheumatol. 2009;28:1167–73.CrossRef Bongi SM, Del Rosso A, Galluccio F, Sigismondi F, Miniati I, Conforti ML, et al. Efficacy of connective tissue massage and Mc Mennell joint manipulation in the rehabilitative treatment of the hands in systemic sclerosis. Clin Rheumatol. 2009;28:1167–73.CrossRef
14.
go back to reference Bongi SM, Del Rosso A, Passalacqua M, Miccio S, Cerinic MM. Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase. Arthritis Care Res. 2011;63:1134–41.CrossRef Bongi SM, Del Rosso A, Passalacqua M, Miccio S, Cerinic MM. Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase. Arthritis Care Res. 2011;63:1134–41.CrossRef
15.
go back to reference Willems LM, Vriezekolk JE, Schouffoer AA, Poole JL, Stamm TA, Boström C, et al. Effectiveness of nonpharmacologic interventions in systemic sclerosis: a systematic review. Arthritis Care Res. 2015;67:1426–39.CrossRef Willems LM, Vriezekolk JE, Schouffoer AA, Poole JL, Stamm TA, Boström C, et al. Effectiveness of nonpharmacologic interventions in systemic sclerosis: a systematic review. Arthritis Care Res. 2015;67:1426–39.CrossRef
16.
go back to reference Discepola MN, Carboni-Jiménez A, Kwakkenbos L, Henry RS, Boruff J, Krishnan A, et al. Effects of non-pharmacological and non-surgical interventions on health outcomes in systemic sclerosis: protocol for a living systematic review. BMJ Open. 2021;11:e047428.CrossRef Discepola MN, Carboni-Jiménez A, Kwakkenbos L, Henry RS, Boruff J, Krishnan A, et al. Effects of non-pharmacological and non-surgical interventions on health outcomes in systemic sclerosis: protocol for a living systematic review. BMJ Open. 2021;11:e047428.CrossRef
17.
go back to reference Sandqvist G, Akesson A, Eklund M. Evaluation of paraffin bath treatment in patients with systemic sclerosis. Disabil Rehabil. 2004;26:981–7.CrossRef Sandqvist G, Akesson A, Eklund M. Evaluation of paraffin bath treatment in patients with systemic sclerosis. Disabil Rehabil. 2004;26:981–7.CrossRef
18.
go back to reference Vannajak K, Boonprakob Y, Eungpinichpong W, Ungpansattawong S, Nanagara R. The short-term effect of gloving in combination with Traditional Thai Massage, heat, and stretching exercise to improve hand mobility in scleroderma patients. J Ayurveda Integr Med. 2014;5:50–5.CrossRef Vannajak K, Boonprakob Y, Eungpinichpong W, Ungpansattawong S, Nanagara R. The short-term effect of gloving in combination with Traditional Thai Massage, heat, and stretching exercise to improve hand mobility in scleroderma patients. J Ayurveda Integr Med. 2014;5:50–5.CrossRef
19.
go back to reference Piga M, Tradori I, Pani D, Barabino G, Dessì A, Raffo L, et al. Telemedicine applied to kinesiotherapy for hand dysfunction in patients with systemic sclerosis and rheumatoid arthritis: recovery of movement and telemonitoring technology. J Rheumatol. 2014;41:1324–33.CrossRef Piga M, Tradori I, Pani D, Barabino G, Dessì A, Raffo L, et al. Telemedicine applied to kinesiotherapy for hand dysfunction in patients with systemic sclerosis and rheumatoid arthritis: recovery of movement and telemonitoring technology. J Rheumatol. 2014;41:1324–33.CrossRef
20.
go back to reference Stefanantoni K, Sciarra I, Iannace N, Vasile M, Caucci M, Sili Scavalli A, et al. Occupational therapy integrated with a self-administered stretching program on systemic sclerosis patients with hand involvement. Clin Exp Rheumatol. 2016;34(Suppl 100):157–61. Stefanantoni K, Sciarra I, Iannace N, Vasile M, Caucci M, Sili Scavalli A, et al. Occupational therapy integrated with a self-administered stretching program on systemic sclerosis patients with hand involvement. Clin Exp Rheumatol. 2016;34(Suppl 100):157–61.
21.
go back to reference Gregory WJ, Wilkinson J, Herrick AL. A randomised controlled trial of wax baths as an additive therapy to hand exercises in patients with systemic sclerosis. Physiotherapy. 2019;105:370–7.CrossRef Gregory WJ, Wilkinson J, Herrick AL. A randomised controlled trial of wax baths as an additive therapy to hand exercises in patients with systemic sclerosis. Physiotherapy. 2019;105:370–7.CrossRef
22.
go back to reference Kristensen LQ, Oestergaard LG, Bovbjerg K, Rolving N, Søndergaard K. Use of paraffin instead of lukewarm water prior to hand exercises had no additional effect on hand mobility in patients with systemic sclerosis: a randomized clinical trial. Hand Therapy. 2019;24:13–21.CrossRef Kristensen LQ, Oestergaard LG, Bovbjerg K, Rolving N, Søndergaard K. Use of paraffin instead of lukewarm water prior to hand exercises had no additional effect on hand mobility in patients with systemic sclerosis: a randomized clinical trial. Hand Therapy. 2019;24:13–21.CrossRef
23.
go back to reference Murphy SL, Barber M, Huang S, Sabbagh M, Cutter G, Khanna D. Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: a pilot two-arm trial. Rheumatology. 2021;60:5002–11.CrossRef Murphy SL, Barber M, Huang S, Sabbagh M, Cutter G, Khanna D. Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: a pilot two-arm trial. Rheumatology. 2021;60:5002–11.CrossRef
24.
go back to reference Gokcen N, Badak SO, Sarpel T, Sertdemir Y, Erken E. The efficacy of a home-based, delf-administered hand exercise program for patients with systemic sclerosis: a randomized controlled, evaluator-blind, clinical trial. J Clin Rheumatol. 2022;28:e422–9.CrossRef Gokcen N, Badak SO, Sarpel T, Sertdemir Y, Erken E. The efficacy of a home-based, delf-administered hand exercise program for patients with systemic sclerosis: a randomized controlled, evaluator-blind, clinical trial. J Clin Rheumatol. 2022;28:e422–9.CrossRef
25.
go back to reference Santos Cardozo Roque LC, Tenório ADS, de Aquino LT, Ferreira RDS, Duarte ALBP, Dantas AT. Joint mobilization and therapeutic exercises in the hands of patients with systemic sclerosis: a preliminary randomized controlled trial. Clin Rehabil. 2022;36:113–24.CrossRef Santos Cardozo Roque LC, Tenório ADS, de Aquino LT, Ferreira RDS, Duarte ALBP, Dantas AT. Joint mobilization and therapeutic exercises in the hands of patients with systemic sclerosis: a preliminary randomized controlled trial. Clin Rehabil. 2022;36:113–24.CrossRef
26.
go back to reference Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJ, van der Giesen FJ, de Jong Z, Stolk J, et al. Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res. 2011;63:909–17.CrossRef Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJ, van der Giesen FJ, de Jong Z, Stolk J, et al. Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res. 2011;63:909–17.CrossRef
27.
go back to reference Rannou F, Boutron I, Mouthon L, Sanchez K, Tiffreau V, Hachulla E, et al. Personalized physical therapy versus usual care for patients with systemic sclerosis: a randomized controlled trial. Arthritis Care Res. 2017;69:1050–9.CrossRef Rannou F, Boutron I, Mouthon L, Sanchez K, Tiffreau V, Hachulla E, et al. Personalized physical therapy versus usual care for patients with systemic sclerosis: a randomized controlled trial. Arthritis Care Res. 2017;69:1050–9.CrossRef
28.
go back to reference Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76:1327–39.CrossRef Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76:1327–39.CrossRef
29.
go back to reference Denton CP, Hughes M, Gak N, Vila J, Buch MH, Chakravarty K, et al. BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology. 2016;55:1906–10.CrossRef Denton CP, Hughes M, Gak N, Vila J, Buch MH, Chakravarty K, et al. BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology. 2016;55:1906–10.CrossRef
30.
go back to reference Kairy D, Lehoux P, Vincent C, Visintin M. A systematic review of clinical outcomes, clinical process, healthcare utilization and costs associated with telerehabilitation. Disabil Rehabil. 2009;31:427–47.CrossRef Kairy D, Lehoux P, Vincent C, Visintin M. A systematic review of clinical outcomes, clinical process, healthcare utilization and costs associated with telerehabilitation. Disabil Rehabil. 2009;31:427–47.CrossRef
31.
go back to reference Ekeland AG, Bowes A, Flottorp S. Effectiveness of telemedicine: a systematic review of reviews. Int J Med Inform. 2010;79:736–71.CrossRef Ekeland AG, Bowes A, Flottorp S. Effectiveness of telemedicine: a systematic review of reviews. Int J Med Inform. 2010;79:736–71.CrossRef
32.
go back to reference Dávalos ME, French MT, Burdick AE, Simmons SC. Economic evaluation of telemedicine: review of the literature and research guidelines for benefit-cost analysis. Telemed J E Health. 2009;15:933–48.CrossRef Dávalos ME, French MT, Burdick AE, Simmons SC. Economic evaluation of telemedicine: review of the literature and research guidelines for benefit-cost analysis. Telemed J E Health. 2009;15:933–48.CrossRef
33.
go back to reference Foster NE, Williams B, Grove S, Gamlin J, Salisbury C. The evidence for and against “PhysioDirect” telephone assessment and advice services. Physiotherapy. 2011;97:78–82.CrossRef Foster NE, Williams B, Grove S, Gamlin J, Salisbury C. The evidence for and against “PhysioDirect” telephone assessment and advice services. Physiotherapy. 2011;97:78–82.CrossRef
34.
go back to reference Cottrell MA, Galea OA, O’Leary SP, Hill AJ, Russell TG. Real-time telerehabilitation for the treatment of musculoskeletal conditions is effective and comparable to standard practice: a systematic review and meta-analysis. Clin Rehabil. 2017;31:625–38.CrossRef Cottrell MA, Galea OA, O’Leary SP, Hill AJ, Russell TG. Real-time telerehabilitation for the treatment of musculoskeletal conditions is effective and comparable to standard practice: a systematic review and meta-analysis. Clin Rehabil. 2017;31:625–38.CrossRef
35.
go back to reference Kwakkenbos L, Jewett LR, Baron M, Bartlett SJ, Furst D, Gottesman K, et al. The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context. BMJ Open. 2013;3:e003563.CrossRef Kwakkenbos L, Jewett LR, Baron M, Bartlett SJ, Furst D, Gottesman K, et al. The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context. BMJ Open. 2013;3:e003563.CrossRef
36.
go back to reference Carrier ME, Kwakkenbos L, Boutron I, Welling J, Sauve M, van den Ende CHM, et al. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise Program (SPIN-HAND): study protocol. J Scleroderma Relat Disord. 2018;3:91–7.CrossRef Carrier ME, Kwakkenbos L, Boutron I, Welling J, Sauve M, van den Ende CHM, et al. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise Program (SPIN-HAND): study protocol. J Scleroderma Relat Disord. 2018;3:91–7.CrossRef
37.
go back to reference Kwakkenbos L, Carrier ME, Welling J, Turner K, Cumin J, Pépin M, et al. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND). PeerJ. 2022;10:e13471. Kwakkenbos L, Carrier ME, Welling J, Turner K, Cumin J, Pépin M, et al. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND). PeerJ. 2022;10:e13471.
38.
go back to reference Relton C, Torgerson D, O’Cathain A, Nicholl J. Rethinking pragmatic randomized controlled trials: introducing the “cohort multiple randomized controlled trial” design. BMJ. 2010;340:c1066.CrossRef Relton C, Torgerson D, O’Cathain A, Nicholl J. Rethinking pragmatic randomized controlled trials: introducing the “cohort multiple randomized controlled trial” design. BMJ. 2010;340:c1066.CrossRef
39.
go back to reference van den Hoogen F, Khanna D, Fransen J, Johnsen SR, Baron M, Tyndall A, et al. Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–47. van den Hoogen F, Khanna D, Fransen J, Johnsen SR, Baron M, Tyndall A, et al. Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737–47.
40.
go back to reference Carrier ME, Kwakkenbos L, Nielson WR, Fedurok C, Nielsen K, Milette K, et al. The Scleroderma Patient-centered Intervention Network self-management program: protocol for a randomized feasibility trial. JMIR Res Protoc. 2020;9:e16799.CrossRef Carrier ME, Kwakkenbos L, Nielson WR, Fedurok C, Nielsen K, Milette K, et al. The Scleroderma Patient-centered Intervention Network self-management program: protocol for a randomized feasibility trial. JMIR Res Protoc. 2020;9:e16799.CrossRef
41.
go back to reference Duruöz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, Dougados M, et al. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol. 1996;23:1167–72. Duruöz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, Dougados M, et al. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol. 1996;23:1167–72.
42.
go back to reference Lamb SE, Williamson EM, Heine PJ, Adams J, Dosanjh S, Dritsaki M, et al. Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial. Lancet. 2015;385:421–9.CrossRef Lamb SE, Williamson EM, Heine PJ, Adams J, Dosanjh S, Dritsaki M, et al. Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial. Lancet. 2015;385:421–9.CrossRef
43.
go back to reference Foster G, Taylor SJ, Eldridge SE, Ramsay J, Griffiths CJ. Self-management education programmes by lay leaders for people with chronic conditions. Cochrane Database Syst Rev. 2007;4:CD005108. Foster G, Taylor SJ, Eldridge SE, Ramsay J, Griffiths CJ. Self-management education programmes by lay leaders for people with chronic conditions. Cochrane Database Syst Rev. 2007;4:CD005108.
44.
go back to reference Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26:1–7.CrossRef Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26:1–7.CrossRef
45.
go back to reference Holman H, Lorig K. Perceived self-efficacy in self-management of chronic disease. In: Schwarzer C, editor. Self-efficacy: thought control of action. Pennsylvania: Taylor & Francis; 1992. p. 305–23. Holman H, Lorig K. Perceived self-efficacy in self-management of chronic disease. In: Schwarzer C, editor. Self-efficacy: thought control of action. Pennsylvania: Taylor & Francis; 1992. p. 305–23.
46.
go back to reference Marks R, Allegrante JP, Lorig K. A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: implications for health education practice (part I). Health Promot Pract. 2005;6:37–43.CrossRef Marks R, Allegrante JP, Lorig K. A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: implications for health education practice (part I). Health Promot Pract. 2005;6:37–43.CrossRef
47.
go back to reference Marks R, Allegrante JP, Lorig K. A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: implications for health education practice (part II). Health Promot Pract. 2005;6:148–56.CrossRef Marks R, Allegrante JP, Lorig K. A review and synthesis of research evidence for self-efficacy-enhancing interventions for reducing chronic disability: implications for health education practice (part II). Health Promot Pract. 2005;6:148–56.CrossRef
49.
go back to reference Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2:197–207.CrossRef Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2:197–207.CrossRef
50.
go back to reference Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281–5. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281–5.
51.
go back to reference Poiraudeau S, Chevalier X, Conrozier T, Flippo RM, Lioté F, Noël E, et al. Reliability, validity, and sensitivity to change of the Cochin Hand Function Disability Scale in hand osteoarthritis. Osteoarthritis Cartilage. 2001;9:570–7.CrossRef Poiraudeau S, Chevalier X, Conrozier T, Flippo RM, Lioté F, Noël E, et al. Reliability, validity, and sensitivity to change of the Cochin Hand Function Disability Scale in hand osteoarthritis. Osteoarthritis Cartilage. 2001;9:570–7.CrossRef
52.
go back to reference Brower LM, Poole JL. Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum. 2004;51:805–9.CrossRef Brower LM, Poole JL. Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum. 2004;51:805–9.CrossRef
53.
go back to reference Hinchcliff M, Beaumont JL, Thavarajah K, Varga J, Chung A, Podlusky S, et al. Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item health profile and Functional Assessment of Chronic Illness Therapy-Dyspnea Short Form. Arthritis Care Res. 2011;63:1620–8.CrossRef Hinchcliff M, Beaumont JL, Thavarajah K, Varga J, Chung A, Podlusky S, et al. Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item health profile and Functional Assessment of Chronic Illness Therapy-Dyspnea Short Form. Arthritis Care Res. 2011;63:1620–8.CrossRef
54.
go back to reference Kwakkenbos L, Thombs BD, Khanna D, Carrier ME, Baron M, Furst DE, et al. Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort study. Rheumatology. 2017;56:1302–11.CrossRef Kwakkenbos L, Thombs BD, Khanna D, Carrier ME, Baron M, Furst DE, et al. Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort study. Rheumatology. 2017;56:1302–11.CrossRef
55.
go back to reference Lineker S, Badley E, Hawker G, Wilkins A. Determining sensitivity to change in outcome measures used to evaluate hydrotherapy exercise programs for people with rheumatic diseases. Arthritis Care Res. 2000;13:62–5.CrossRef Lineker S, Badley E, Hawker G, Wilkins A. Determining sensitivity to change in outcome measures used to evaluate hydrotherapy exercise programs for people with rheumatic diseases. Arthritis Care Res. 2000;13:62–5.CrossRef
57.
go back to reference Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.CrossRef Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.CrossRef
58.
go back to reference Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc. 1996;91:444–55.CrossRef Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc. 1996;91:444–55.CrossRef
59.
go back to reference Imbens GW, Angrist JD. Identification and estimation of local average treatment effects. Econometrica. 1994;62:467–75.CrossRef Imbens GW, Angrist JD. Identification and estimation of local average treatment effects. Econometrica. 1994;62:467–75.CrossRef
60.
go back to reference van der Leeden R, Busing FMTA, Meijer E. In: Bootstrap methods for two-level models. The Netherlands: Technical Report PRM 97–04, Leiden University, Department of Psychology, Leiden; 1997. van der Leeden R, Busing FMTA, Meijer E. In: Bootstrap methods for two-level models. The Netherlands: Technical Report PRM 97–04, Leiden University, Department of Psychology, Leiden; 1997.
61.
go back to reference van der Leeden R, Meijer E, Busing FMTA. Chapter 11: Resampling multilevel models. In: Leeuw J, Meijer E, editors. Handbook of multilevel analysis. New York: Springer; 2008. p. 401–33.CrossRef van der Leeden R, Meijer E, Busing FMTA. Chapter 11: Resampling multilevel models. In: Leeuw J, Meijer E, editors. Handbook of multilevel analysis. New York: Springer; 2008. p. 401–33.CrossRef
62.
go back to reference Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–43.CrossRef Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–43.CrossRef
63.
go back to reference Zelen M. Randomized consent designs for clinical trials: an update. Stat Med. 1990;9:645–56.CrossRef Zelen M. Randomized consent designs for clinical trials: an update. Stat Med. 1990;9:645–56.CrossRef
64.
go back to reference Schellings R, Kessels AG, ter Riet G, Sturmans F, Widdershoven GA, Knottnerus JA. Indications and requirements for the use of prerandomization. J Clin Epidemiol. 2009;62:393–9.CrossRef Schellings R, Kessels AG, ter Riet G, Sturmans F, Widdershoven GA, Knottnerus JA. Indications and requirements for the use of prerandomization. J Clin Epidemiol. 2009;62:393–9.CrossRef
65.
go back to reference Simon GE, Shortreed SM, DeBar LL. Zelen design clinical trials: why, when, and how. Trials. 2021;22:541.CrossRef Simon GE, Shortreed SM, DeBar LL. Zelen design clinical trials: why, when, and how. Trials. 2021;22:541.CrossRef
66.
go back to reference Viksveen P, Relton C, Nicholl J. Depressed patients treated by homeopaths: a randomized controlled trial using the “cohort multiple randomized controlled trial”(cmRCT) design. Trials. 2017;18:299.CrossRef Viksveen P, Relton C, Nicholl J. Depressed patients treated by homeopaths: a randomized controlled trial using the “cohort multiple randomized controlled trial”(cmRCT) design. Trials. 2017;18:299.CrossRef
67.
go back to reference Reeves D, Howells K, Sidaway M, Blakemore A, Hann M, Panagioti M, et al. The cohort multiple randomized controlled trial design was found to be highly susceptible to low statistical power and internal validity biases. J Clin Epidemiol. 2018;95:111–9.CrossRef Reeves D, Howells K, Sidaway M, Blakemore A, Hann M, Panagioti M, et al. The cohort multiple randomized controlled trial design was found to be highly susceptible to low statistical power and internal validity biases. J Clin Epidemiol. 2018;95:111–9.CrossRef
68.
go back to reference Gal R, Monninkhof EM, van Gils CH, Groenwold RHH, Elias SG, van den Bongard DHJG, et al. Effects of exercise in breast cancer patients: implications of the trials withing cohorts (TwiCs) design in the UMBRELLA Fit trial. Breast Cancer Res Treat. 2021;190:89–101.CrossRef Gal R, Monninkhof EM, van Gils CH, Groenwold RHH, Elias SG, van den Bongard DHJG, et al. Effects of exercise in breast cancer patients: implications of the trials withing cohorts (TwiCs) design in the UMBRELLA Fit trial. Breast Cancer Res Treat. 2021;190:89–101.CrossRef
69.
go back to reference Simon GE, Beck A, Rossom R, Richards J, Kirlin B, King D, et al. Population-based outreach versus care as usual to prevent suicide attempt: study protocol for a randomized controlled trial. Trials. 2016;17:452.CrossRef Simon GE, Beck A, Rossom R, Richards J, Kirlin B, King D, et al. Population-based outreach versus care as usual to prevent suicide attempt: study protocol for a randomized controlled trial. Trials. 2016;17:452.CrossRef
70.
go back to reference Faseru B, Ellerbeck EF, Catley D, Gajewski BJ, Scheuermann TS, Shireman TI, et al. Changing the default for tobacco-cessation treatment in an inpatient setting: study protocol of a randomized controlled trial. Trials. 2017;18:379.CrossRef Faseru B, Ellerbeck EF, Catley D, Gajewski BJ, Scheuermann TS, Shireman TI, et al. Changing the default for tobacco-cessation treatment in an inpatient setting: study protocol of a randomized controlled trial. Trials. 2017;18:379.CrossRef
71.
go back to reference Kwakkenbos L, Østbø N, Carrier ME, Nielson WR, Fedoruk C, Levis B, et al. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) program. Pilot Feasibility Stud. 2022;8:45.CrossRef Kwakkenbos L, Østbø N, Carrier ME, Nielson WR, Fedoruk C, Levis B, et al. Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) program. Pilot Feasibility Stud. 2022;8:45.CrossRef
72.
go back to reference Daste C, Rannou F, Mouthon L, Sanchez K, Roren A, Tiffreau V, et al. Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: a secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care. Semin Arthritis Rheum. 2019;48:694–700.CrossRef Daste C, Rannou F, Mouthon L, Sanchez K, Roren A, Tiffreau V, et al. Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: a secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care. Semin Arthritis Rheum. 2019;48:694–700.CrossRef
73.
go back to reference Scholten MR, Kelders SM, Van Gemert-Pijnen JE. Self-guided web-based interventions: scoping review on user needs and the potential of embodied conversational agents to address them. J Med Internet Res. 2017;19:e383.CrossRef Scholten MR, Kelders SM, Van Gemert-Pijnen JE. Self-guided web-based interventions: scoping review on user needs and the potential of embodied conversational agents to address them. J Med Internet Res. 2017;19:e383.CrossRef
74.
go back to reference Schubart JR, Stuckey HL, Ganeshamoorthy A, Sciamanna CN. Chronic health conditions and internet behavioral interventions: a review of factors to enhance user engagement. Comput Inform Nurs. 2011;29:81–92.CrossRef Schubart JR, Stuckey HL, Ganeshamoorthy A, Sciamanna CN. Chronic health conditions and internet behavioral interventions: a review of factors to enhance user engagement. Comput Inform Nurs. 2011;29:81–92.CrossRef
75.
go back to reference McKay HG, King D, Eakin EG, Seeley JR, Glasgow RE. The diabetes network internet-based physical activity intervention: a randomized pilot study. Diabetes Care. 2001;24:1328–34.CrossRef McKay HG, King D, Eakin EG, Seeley JR, Glasgow RE. The diabetes network internet-based physical activity intervention: a randomized pilot study. Diabetes Care. 2001;24:1328–34.CrossRef
76.
go back to reference Nordlund J, Henry RS, Kwakkenbos L, Carrier ME, Levis B, Nielson WR, et al. The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial. Trials. 2021;22:856. Nordlund J, Henry RS, Kwakkenbos L, Carrier ME, Levis B, Nielson WR, et al. The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial. Trials. 2021;22:856.
77.
go back to reference Thombs BD, Kwakkenbos L, Levis B, Bourgeault A, Henry RS, Levis AW, et al. Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trial. Lancet Rheumatol. 2021;3:e427–37.CrossRef Thombs BD, Kwakkenbos L, Levis B, Bourgeault A, Henry RS, Levis AW, et al. Effects of a multi-faceted education and support programme on anxiety symptoms among people with systemic sclerosis and anxiety during COVID-19 (SPIN-CHAT): a two-arm parallel, partially nested, randomised, controlled trial. Lancet Rheumatol. 2021;3:e427–37.CrossRef
78.
go back to reference Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, et al. The Scleroderma Patient-Centered Intervention Network (SPIN) Cohort: baseline clinical features and comparison to other large scleroderma cohorts. Rheumatology. 2018;57:1623–31.CrossRef Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, et al. The Scleroderma Patient-Centered Intervention Network (SPIN) Cohort: baseline clinical features and comparison to other large scleroderma cohorts. Rheumatology. 2018;57:1623–31.CrossRef
Metadata
Title
Randomized controlled trial of an internet-based self-guided hand exercise program to improve hand function in people with systemic sclerosis: the Scleroderma Patient-centered Intervention Network Hand Exercise Program (SPIN-HAND) trial
Authors
Linda Kwakkenbos
Marie-Eve Carrier
Joep Welling
Brooke Levis
Alexander W. Levis
Maureen Sauve
Kimberly A. Turner
Lydia Tao
Kylene Aguila
Andrea Carboni-Jiménez
Mara Cañedo-Ayala
Sami Harb
Cornelia van den Ende
Marie Hudson
Ward van Breda
Christelle Nguyen
Isabelle Boutron
François Rannou
Brett D. Thombs
Luc Mouthon
on behalf of the SPIN Investigators
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06923-4

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue